Shares of our common stock are listed on the NASDAQ OTC market and trade under the symbol “UEEC“.
For more information, please contact investor@uhpcorp.com
For press and media relations, please contact media@uhpcorp.com
Press Releases
-
United Health Products Provides Regulatory Application Update
Mount Laurel, New Jersey – June 6, 2025 – United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussion with the Food & Drug Administration. As previously disclosed, the review by FDA’s Office of Product Evaluation and Quality of its Investigational Device Exemption (IDE) application to conduct the follow-on clinical study of…
-
United Health Products Announces OTCQB Uplisting and FDA Update
Mount Laurel, New Jersey – May 1, 2025 – United Health Products, Inc. (OTCQB: UEEC) is pleased to announce that it has been approved to have its common shares uplisted from the OTC “Pink” market to the OTCQB Venture Market (“OTCQB”). The successful uplisting is effective May 1, 2025 and the company’s common shares will continue…
-
United Health Products Provides Update on FDA and OTC Markets Applications
Mount Laurel, New Jersey – March 28, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, the FDA requested that certain additional sterilization and biocompatibility tests be included in the company’s Investigational Device Exemption (IDE) application. An IDE approval is a…
-
United Health Products Provides Update on Capital Markets and Regulatory Processes
Mount Laurel, New Jersey – March 13, 2025 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, UHP has submitted an application to OTC Markets to have its common shares quoted on the OTCQB market, which the company believes will increase the…